Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangzhong Pharmaceutical Co Ltd    600750   CNE000000M80

End-of-day quote. End-of-day quote  - 05/06
29.52 CNY   -5.93%
 SummaryQuotesChartsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
04/29/2016 05/03/2016 05/04/2016 05/05/2016 05/06/2016 Date
30.28(c) 31.38(c) 31.72(c) 31.38(c) 29.52 Last
3 458 426 6 477 138 6 960 945 7 885 036 11 828 006 Volume
-0.30% +3.63% +1.08% -1.07% -5.93% Change
More quotes
Financials ( CNY)
Sales 2016 3 550 M
EBIT 2016 546 M
Net income 2016 437 M
Finance 2016 833 M
Yield 2016 1,40%
Sales 2017 3 884 M
EBIT 2017 613 M
Net income 2017 518 M
Finance 2017 1 087 M
Yield 2017 1,66%
P/E ratio 2016 21,52
P/E ratio 2017 18,16
EV / Sales 2016 2,42x
EV / Sales 2017 2,14x
Capitalization 9 414 M
More Financials
Company
Jiangzhong Pharmaceutical Co. Ltd. is engaged in the manufacture and sale of pharmaceutical products.Main products consist of Chinese, water-soluble and botanical medicines; penicillin injection and raw materials; capsules; antibiotics and others.Other activities include wholesale and retail of... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Jiangzhong Pharmaceutical
Trading Rating : Investor Rating : -
More Ratings
Latest news on JIANGZHONG PHARMACEUTICAL

- No features available -

More news
Sector news : Pharmaceuticals - NEC
05:20p PFIZER : Another Drug Settlement Boosts General Fund
03:37pDJU.S. HOT STOCKS : Hot Stocks to Watch
02:52p ABBVIE : NICE recommends adalimumab for hidradenitis suppurativa
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart JIANGZHONG PHARMACEUTICAL
Duration : Period :
Jiangzhong Pharmaceutical  Technical Analysis Chart | 600750 | CNE000000M80 | 4-Traders
Full-screen chart
Technical analysis trends JIANGZHONG PHARMA...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions